This media is not supported in your browser
VIEW IN TELEGRAM
🚀 Flagship Pioneering Raises $3.6B! 🧬
Flagship Pioneering has expanded its capital base by $3.6B to support the creation of 25 breakthrough companies in human health, sustainability, and AI. This brings their total capital raised since 2021 to $6.4B!
🔬 “Our focus is on pioneering original science to invent transformative technologies that improve human health and our planet,” says Flagship Pioneering Founder & CEO Noubar Afeyan.
🏢 Flagship has expanded globally with hubs in London and Singapore, through collaborations and partnerships with industry giants like Pfizer and Samsung.
👥 Flagship's portfolio includes innovative companies like Moderna, Generate Biomedicines, Indigo Agriculture, Foghorn Therapeutics, and Tessera Therapeutics.
This news and this one demonstrate the strength and power of the Diaspora. Its potential in transforming Armenia into an innovation hub is obviously underused.
https://t.me/threenstartups
#biotech #ai #flagshippioneering #investment #healthtech #noubarafeyan
Flagship Pioneering has expanded its capital base by $3.6B to support the creation of 25 breakthrough companies in human health, sustainability, and AI. This brings their total capital raised since 2021 to $6.4B!
🔬 “Our focus is on pioneering original science to invent transformative technologies that improve human health and our planet,” says Flagship Pioneering Founder & CEO Noubar Afeyan.
🏢 Flagship has expanded globally with hubs in London and Singapore, through collaborations and partnerships with industry giants like Pfizer and Samsung.
👥 Flagship's portfolio includes innovative companies like Moderna, Generate Biomedicines, Indigo Agriculture, Foghorn Therapeutics, and Tessera Therapeutics.
This news and this one demonstrate the strength and power of the Diaspora. Its potential in transforming Armenia into an innovation hub is obviously underused.
https://t.me/threenstartups
#biotech #ai #flagshippioneering #investment #healthtech #noubarafeyan
🔥5
DayOne Accelerator is a 3-month hybrid, equity-free program based in Basel, Switzerland🇨🇭, supporting early-stage digital health, medtech, and techbio startups focused on pharma R&D.
It offers hands-on mentorship, access to pharma industry experts, non-dilutive funding CHF 50K (~$60K), and office space. Selected startups also gain a path to long-term partnerships and post-accelerator support.
Applications close May 15, 2025.
Find More and Apply here: https://www.dayone.swiss/accelerator/
#HealthTech #MedTech #Pharma #LifeSciences #StartupAccelerator #SwissInnovation #DayOneAccelerator
—————————————————
🔥 Join 3N to stay updated on startup opportunities!
It offers hands-on mentorship, access to pharma industry experts, non-dilutive funding CHF 50K (~$60K), and office space. Selected startups also gain a path to long-term partnerships and post-accelerator support.
Applications close May 15, 2025.
Find More and Apply here: https://www.dayone.swiss/accelerator/
#HealthTech #MedTech #Pharma #LifeSciences #StartupAccelerator #SwissInnovation #DayOneAccelerator
—————————————————
🔥 Join 3N to stay updated on startup opportunities!
👍1🔥1